or Try an Advanced Search...

    Technical Analysis for NTBL - Notable Labs, Ltd.

    Grade Last Price % Change Price Change
    F 0.97 0.51% 0.00
    NTBL closed up 0.51 percent on Friday, April 26, 2024, on 1.61 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 13
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NTBL trend table...
    Date Alert Name Type % Chg
    Shooting Star Candlestick Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 0.51%
    Oversold Stochastic Weakness 0.51%
    180 Bearish Setup Bearish Swing Setup -1.63%
    Calm After Storm Range Contraction -1.63%
    NR7 Range Contraction -1.63%
    Narrow Range Bar Range Contraction -1.63%
    Wide Bands Range Expansion -1.63%
    Older End-of-Day Signals for NTBL ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 16 hours ago
    1.5x Volume Pace about 16 hours ago
    Up 5% about 16 hours ago
    Up 10% about 16 hours ago
    10 DMA Resistance about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NTBL Chart by TradingView
    Basic chart:

    Profile

    Notable Labs, Ltd. Description

    Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cancer Treatment Acute Myeloid Leukemia Orphan Drug Protein Kinase Inhibitor Myelodysplastic Syndrome Chronic Myeloid Leukemia Kinase 1 Lintuzumab

    Is NTBL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 9 Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
    Apr 8 Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
    Mar 5 Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
    Dec 13 Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes
    Dec 11 Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant
    Dec 4 Notable Labs to Participate in JMP Securities Hematology and Oncology Summit
    Nov 14 Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
    Nov 9 Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML
    See more NTBL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.2
    52 Week Low 0.833
    Average Volume 88,635
    200-Day Moving Average 4.20
    50-Day Moving Average 1.40
    20-Day Moving Average 1.24
    10-Day Moving Average 0.99
    Average True Range 0.13
    RSI (14) 29.08
    ADX 31.55
    +DI 16.65
    -DI 29.60
    Chandelier Exit (Long, 3 ATRs) 1.51
    Chandelier Exit (Short, 3 ATRs) 1.21
    Upper Bollinger Bands 1.81
    Lower Bollinger Band 0.66
    Percent B (%b) 0.27
    BandWidth 93.35
    MACD Line -0.16
    MACD Signal Line -0.14
    MACD Histogram -0.0238
    Fundamentals Value
    Market Cap 8.69 Million
    Num Shares 9 Million
    EPS -1.61
    Price-to-Earnings (P/E) Ratio -0.60
    Price-to-Sales 90.01
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.14
    Resistance 3 (R3) 1.16 1.11 1.11
    Resistance 2 (R2) 1.11 1.07 1.11 1.10
    Resistance 1 (R1) 1.04 1.04 1.02 1.02 1.09
    Pivot Point 1.00 1.00 0.98 0.99 1.00
    Support 1 (S1) 0.92 0.95 0.90 0.91 0.84
    Support 2 (S2) 0.88 0.92 0.87 0.83
    Support 3 (S3) 0.80 0.88 0.82
    Support 4 (S4) 0.79